400 SL SL (Gleevec 400 mg)

Generic Name: imatinib

Pill imprint 400 SL SL has been identified as Gleevec 400 mg.

Gleevec is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; myeloproliferative disorders; acute lymphoblastic leukemia; chronic eosinophilic leukemia (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gleevec 400 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 400 SL SL

Gleevec 400 mg 400 SL SL Front
Gleevec 400 mg 400 SL SL Back
Gleevec 400 mg 400 SL SL
Gleevec
Generic Name:
imatinib
Imprint:
400
SL SL
Strength:
400 mg
Color:
Orange
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)